High visibility efforts in toxicity testing and computational toxicology including the recent National Research Council of the National Academies (NRC) report, Toxicity Testing in the 21st Century: A Vision and Strategy (NRC, 2007a), raise important research questions and opportunities for the field of exposure science. The authors of the National Academies report (NRC, 2007a) emphasize that population-based data and human exposure information are required at each step of their vision for toxicity testing and that these data will continue to play a critical role in both guiding development and use of the toxicity information. In fact, state-of-the-art exposure science is essential for translation of toxicity data to assess potential for risk to individuals and populations and to inform public health decisions. As we move forward to implement the NRC vision, a transformational change in exposure science is required. Application of a fresh perspective and novel techniques to capture critical determinants at biologically motivated resolution for translation from controlled in vitro systems to the open multifactorial system of real-world human-environment interaction will be critical. Development of an exposure ontology and knowledgebase will facilitate extension of network analysis to the individual and population for translating toxicity information and assessing health risk. Such a sea change in exposure science is required to incorporate consideration of lifestage, genetic susceptibility, and interaction of nonchemical stressors for holistic assessment of risk factors associated with complex environmental disease. A new generation of scientific tools has emerged to rapidly measure signals from cells, tissues, and organisms following exposure to chemicals. Investment in 21st century exposure science is now required to fully realize the potential of the NRC vision for toxicity testing.
The National Research Council of the National Academies (NRC) report, Toxicity Testing in the 21st Century: A Vision and Strategy (NRC, 2007a) , articulates a long-range vision and promotes a transformation in toxicity testing based on a rapidly evolving understanding of molecular pathways-the role of these in normal cell function and in toxicity. The key aspect of the NRC vision and proposed paradigm shift in toxicity testing is that new tools are available to examine toxicity pathways in a depth and breadth that has not been possible before. In response to the NRC report, efforts underway to apply highthroughput screening (HTS) approaches for chemical prioritization and toxicity testing have been accelerated (Collins et al., 2008; Dix et al., 2007) . As a result, an explosion of HTS data for in vitro toxicity assays will become available over the next few years. How will this new toxicity information be translated to assess potential for risks to individuals and populations from environmental exposures and to improve public health?
The authors of the National Academies report (NRC, 2007a ) emphasize that population-based data and human exposure information are required at each step of their vision for toxicity testing. Exposure needs highlighted in the NRC report include (1) human exposure data to select doses for toxicity testing and facilitate development of environmentally relevant hazard information, (2) biomonitoring data relating real-world human exposures with concentrations that perturb toxicity pathways to identify biologically relevant exposures, and (3) information on host susceptibility and background exposures to interpret and extrapolate (i.e., translate) in vitro test results for risk assessment. While the importance of exposure information for design and interpretation of toxicity testing under the NRC vision was clearly identified, it was beyond the charge of the committee to address the required science and resources to meet this need. As a result, current discrepancies in the scientific foundation for hazard and exposure characterization are rapidly increasing.
Others, however, have recognized that just as interpretation of toxicogenomic hazard data require anchoring to apical end points for contextual relevance, understanding relevant perturbations leading to these toxicogenomic end points requires anchoring stressors to real-world human exposure (biologically relevant exposure metrics). New approaches for toxicity testing and risk assessment require systems-based consideration of interactions between exposure and effect as well as the science to predict exposures down to the molecular level (Cohen Hubal et al., 2008b; Edwards and Preston, 2008; Sheldon and Cohen Hubal, 2009 ). Wild (2005) has proposed the need for a step change in exposure assessment and has articulated a vision for exposure measurement commensurate with that of the NRC vision for toxicity testing. Wild has called for an exposome or measurement of the life-course of environmental exposures to provide the evidence base for public health decisions to address environmental health. Wild et al. (2005) discuss the potential of emerging technologies to provide this new generation of exposure information. Finally, Lange et al. (2007) have discussed the need to integrate heterogeneous ontologies into interdisciplinary knowledge systems to unify scientific fields and harness the full potential of exposure and health outcome data. Lange et al. illustrate a framework and call for development of a knowledge system to seamlessly compute relationships across the source-to-outcome continuum.
In this paper, the case is presented for a transformation in exposure science commensurate with the transformation in toxicology presented by the NRC. A new generation of tools to rapidly characterize biologically relevant exposures and link to environmentally relevant hazard is required to employ toxicity data for holistic risk assessment and to inform public health decisions. Research initiatives required to develop this exposure science include (1) application of systems biology network modeling to identify exposure metrics and models for characterizing key stressors at biologically motivated resolution, (2) development and application of advanced technologies to measure key exposure metrics (e.g., biomarkers to measure internal exposure, sensors to measure personal exposure), and (3) development of an exposure-hazard knowledge system to facilitate risk assessment. The imperative for this transformation and an outline of the required initiatives follow.
THE CASE FOR EXPOSURE
Exposure characterization is the risk analysis step in which human interaction with an environmental agent of concern is evaluated. Exposure is defined as the contact between an agent and a target (WHO, 2004) . Although the primary application of this definition for risk assessment has been to the individual or human population as a target of exposure and a chemical as an agent of exposure, the target of exposure can be an organ, tissue, or cell and the agent of exposure can be a biological, physical, or psychosocial stressor or the by-product of given exposure agent (Fig. 1) . Exposure assessment is defined as evaluation of exposure of a system, organism, or (sub)-population to an agent (and its derivatives). The process may include estimating the magnitude, frequency, and duration of an exposure, along with characteristics of the exposed individual or population (WHO, 2004) . In limited cases, exposure can be measured directly, but more often due to current scientific limitations, exposure must be estimated (Cohen Hubal et al., 2008a; Paustenbach, 2000) .
Low-level and prevalent environmental exposures may contribute substantially to the burden of common complex disease (Gibson, 2008; Hemminki et al., 2006) . Understanding the relationships between environmental exposures and health outcomes requires integration of a wide range of factors-extrinsic (e.g., environmental), intrinsic (e.g., genotypic), and mechanistic (e.g., toxicological)-to support health studies and characterize risk. Assessing complex human health risks associated with exposures to chemicals requires that hazard, susceptibility, and exposure are all reliably characterized.
Characterization of susceptibility is rapidly advancing through application of microarray technology for genotyping and investment in large genome-wide association studies (McCarthy et al., 2008) . Epidemiologists are now facing the challenges associated with interpreting this massive amount of genomic variation data for understanding etiology of complex environmental disease. Calls for tools to characterize and unravel interacting genetic and environmental factors have begun (Collins, 2006; Manolio and Collins, 2007) . Similarly, the NRC has presented a vision for advancing characterization of hazard through application of HTS methods and system biology approaches to elucidate toxicity pathways. As a result, toxicologists are facing the challenges of translating the high content toxicity data that is now being generated (Dix et al., 2007) to inform risk assessment. The high-priority need for research to interpret these hazard data in the context of realworld exposure has been identified by risk assessors. At the same time, however, characterization of exposure remains primitive by comparison (e.g., scenario-based assessment of exposures-sentinel products in nonstandardized scenarios vs. measurement of real-time personal exposure) and resources to improve the scientific basis of exposure assessment are limited or nonexistent. This lack of balance in efforts to improve measuring hazard and exposure is less than ideal for providing advancement in risk assessment.
Just as Wild (2005) questions whether or not fundamental knowledge about genetics will improve understanding of disease etiology at the population level, we should question whether or not fundamental knowledge of toxicity pathways will improve understanding of real-world human health risk. Accurate assessment of chemical exposures remains an outstanding and largely unmet challenge in toxicology and risk assessment. One side of the hazard-exposure equation continues to be refined, while the other remains subject to crude characterization based largely on indirect estimates and default assumptions. Due to the complex nature of the human system, predictions of potential health risks associated with chemical exposures will be limited by the least resolved or least understood component of the system. By focusing resources exclusively on improving hazard characterization, we compromise the ability to fully realize benefits of the NRC vision. Just as a new generation of scientific tools is being applied to rapidly assess toxic response resulting from chemical EXPOSURE AND THE NRC VISION 227 exposures, there is a critical need to develop methods for characterizing environmental exposures at biologically relevant resolution to translate HTS toxicity results for human health risk assessment.
REQUIRED INITIATIVES
What does the real world look like and how can we capture a picture (i.e., model) of the real world that will facilitate risk assessment and allow us to make important environmental health decisions? Understanding relationships among multiple environmental factors and complex disease as well as characterizing environmental health risk factors requires collection and analysis of a wide range of data. Information on the characteristics of multiple stressors (chemical, physical, biological, and psychosocial) , the characteristics of the human receptor (genetics, health status, life stage, behaviors, social factors, etc.) at multiple levels of organization (individual, community, population) , and the temporal and spatial patterns of exposures and outcomes must be considered. Strategic research is required to identify key determinants of exposure to capture the essence of this multifactorial reality. What are the critical elements of exposure in a given context? What are the key metrics for characterizing these exposure elements in that context? What is the required resolution for measuring key metrics and modeling exposures so that these are relevant for developing and interpreting hazard information to assess health risks? Finally, can new scientific understanding and tools in biological, computational, and information sciences be leveraged to develop rapid inexpensive approaches for characterizing biologically relevant exposure?
Under the NRC vision, tools developed by the pharmaceutical industry are being applied to transform toxicity testing.
Similarly, exposure scientists must leverage advanced measurement and computational tools from disparate but related fields to transform exposure science. New technologies must be applied to move from our current crude indirect estimates of exposure to the biologically based metrics required to interpret emerging toxicity data and advance human health risk assessment. In addition, the complexity of the multifactorial systems under study and the resulting multidimensional data produced using emerging technologies require application of environmental informatic capabilities and advanced computational tools to model and link exposures to health outcomes. A combination of discovery and engineering (mechanistic)-based modeling approaches for hypothesis development and testing are required. Statistical data-mining and machine-learning approaches are required to extract information from extant data on critical exposure determinants, link exposure information with toxicity data, and identify limitations and gaps in exposure data. Engineering or mechanistic approaches are required to model the human-environment system and to test our understanding of this system.
Systems Biology: Exposure at All Levels of Biological Organization
In the NRC vision, the authors propose systems biology evaluation of signaling networks to characterize perturbations of toxicity pathways and as the basis of a new toxicity-testing paradigm. Environmental stressors (i.e., exposure) leading to perturbations of toxicity pathways are simplified and treated as unidirectional and one-dimensional. Fortunately, systems theory also provides the required conceptual framework for linking exposure science and toxicology to study, characterize, and make predictions about the complex interactions between humans and environmental chemicals and associated feedback 228 HUBAL across levels of biological organization (Fig. 1) . A systems biology approach for holistic study of environmental disease and risk assessment considers coupled networks that span multiple levels of biological organization. These networks describe the overall connectivity of the system. Mechanistic understanding is derived by characterization of these networks and impacts of perturbations due to behavioral and environmental influences. Edwards and Preston (2008) present the conceptual basis for extending network analysis to inform risk assessment. Networks at different levels of the system can be used to merge molecular-level changes with measured events at the individual or population level. Molecular networks are developed based on data from Omic measurements. Key event networks, where each node ideally represents a toxicity pathway, are abstracted from the molecular network based on biological interpretation and targeted experimentation (both in vitro and in vivo). Adverse outcomes are driven by the impact of an individual's genetics, epigenetics, and exposure profile. Connectivity at the population level is driven by common genetics, lifestyle, and environment. An example of the type of approach described by Edwards and Preston has been partially demonstrated for an ecological model of endocrine disruption (Ankley et al., 2009) . Gohlke et al. (2009) present an example of how this approach can be applied using gene-centered databases to develop linked networks to explore interplay between genetic and environmental factors for metabolic syndrome and neuropsychiatric disorders. The analysis presented by Gohlke et al. highlights significant gaps in exposure information required to extend this approach to assess and mitigate human health risks. The Comparative Toxicogenomic Database (CTD) (Davis et al., 2008) used to compile environmental factor-gene/protein relationships does indeed provide an important model for how exposure information can and should be made accessible to facilitate investigation of gene-environment-disease relationships. However, because the CTD is limited to curated information on direct chemical-gene interactions and direct gene-disease associations, chemical-disease relationships must be inferred. Here, again, real-world exposure information is required to translate molecular insights to assess risks to individuals and populations.
Just as key cellular processes may be associated with multiple complex outcomes, it is likely that exposures to multiple xenobiotic compounds may elicit perturbation of the same key toxicity pathways. Understanding the critical determinants of multifactorial perturbations and feedback in the human-environment system is required to interpret toxicity data for risk assessment. A systems approach for assessing risk provides a holistic view of interactions between a chemical stressor and biological entity from the molecular level through to the level of the organism and/or population (Fig. 1) . Such a holistic systems approach demands exposure metrics and models to characterize key stressors at a level of resolution commensurate with that of the response or effects (biologically motivated resolution).
Biologically Relevant Exposure Metrics
The major challenge to realizing the full potential of the NRC vision is the limited availability of efficient and affordable methods for measuring biologically relevant exposures. Biologically relevant exposure metrics are those that can be directly associated with key events in a disease process and with an individual's exposure profile.
Based on this need to characterize biologically relevant environmental exposures, Wild (2005) has proposed investment in development of exposure biomarkers to improve our ability to understand and mitigate environmental impacts on human health. In fact, we are faced with the same critical need for advanced exposure science if we are to realize the NRC vision. Though Wild's vision for an exposome has been articulated in the context of characterizing the environmental contribution to etiology of common complex disease, the basic principles behind this call are germane for human health risk assessment. As early as 1999, Groopman and Kensler (1999) highlighted the challenges associated with developing biomarkers and interpreting biomarker data to sort out the interactions of multiple chemicals, multiple exposures, and relation of these to health outcomes. With appropriate investment, a new generation of technologies may provide the tools to address some of these challenges. Limited examples follow, but opportunities to adapt a wide range of sensors and biomarkers to measure chemical stressors and/or derivatives of these at all levels of biological organization should be considered.
Currently, as advocated by the NRC vision, investment in Omic technologies is focused on understanding and characterizing toxicity or hazard. Yet, these tools may also yield a new generation of exposure metrics. In a second report (NRC, 2007b) , the NRC has called for further development of toxicogenomic technologies to increase capabilities in exposure assessment. There are early indications that with appropriate investment, this area of research could provide important approaches for assessing real-world exposures. Wild (2009) considers application of transcriptomics for development of exposure biomarkers to improve exposure assessment in epidemiology. Fry et al. (2007) present an exciting example of the potential to link environmental exposure and altered gene expression. In a study conducted in Thailand, Fry et al. identified expression signatures from babies born to arsenicunexposed and -exposed mothers that were highly predictive of prenatal arsenic exposure in a subsequent test population. Resulting signatures, based on a very small number of genes, show promise as biomarkers of arsenic exposure. Other studies have investigated altered global gene expression associated with exposure to cigarette smoke, benzene, metal fumes, and air pollution. While the limited research conducted to date suggests that environmental exposures elicit changes in gene expression specific to the type of exposure, significant scientific hurdles remain. However, careful targeted investment EXPOSURE AND THE NRC VISION 229 should be directed to develop Omic tools to link real-world exposure and in vitro hazard information.
Biomarkers alone will not provide the full range of information required to characterize exposure and make critical links to hazard for risk assessment. Direct, noninvasive, and sensitive detection of chemical stressors in relevant environmental and biological media could prove to be the most effective means of assessing exposure. Recently, Schwartz and Collins (2007) identified the need for better environmental biosensors to study gene-environment interactions associated with complex disease. Research in this area is also required to apply toxicity-testing results to assess human health risk. Advances in nanotechnology and related development of small-scale sensors promise to facilitate comprehensive monitoring of exposure, dose, and associated indicators of early effect. Nanotechnologies offer the potential to improve exposure and risk assessment by facilitating collection of large numbers of measurements on very small numbers of molecules at a low cost. It is currently possible to develop microscale and nanoscale sensor arrays that can detect specific sets of harmful agents in the environment (Andreescu et al., 2009) . Provided adequate informatics support, these sensors can be used to monitor multiple agents in real time and the resulting data can be accessed remotely. The potential also exists to extend these small-scale monitoring systems to the individual level to detect personal and in vivo distributions of toxicants (Barry et al., 2009; Weis et al., 2005) .
Together, application and development of exposure assessment tools such as advanced molecular indicators of exposure (Sen et al., 2007; Wild, 2009 ) and nanotechnologybased sensors (Andreescu et al., 2009; Barry et al., 2009) present the opportunity for simultaneous measurement of biologically relevant exposures to multiple real-world stressors as well as the potential to mechanistically link traditional exposure metrics and end points measured in HTP in vitro assays.
Exposure Hazard Knowledge System
The NRC vision emphasized the importance of extrapolation modeling to (1) provide quantitative mechanistic understanding of dose-response relationship for perturbations by environmental agents, (2) predict human exposures leading to tissue concentrations comparable to concentrations causing perturbations in vitro, and (3) provide a basis for addressing background chemical exposures, background disease processes, and host susceptibility (NRC, 2007a) . Development and use of models that can efficiently address these critical components for translation and risk assessment requires capabilities to collect, organize, retrieve, and link large amounts of disparate multidimensional exposure and hazard information.
Significant energy and resources have been committed to collate and improve access to genomic, toxicology, and health data (Davis et al., 2008; Judson et al., 2008; Richard et al., 2008) . Lacking from these information resources is the realworld exposure data required to translate molecular insights for assessing risks at the individual and population level. Knowledge discovery-based tools are new to the exposure science community. Yet, these tools are absolutely critical as these provide the opportunity to efficiently leverage exposure information for extrapolation modeling and translation of in vitro HTS toxicity data for risk assessment.
Translation of the hazard information developed under the NRC vision will require a holistic risk assessment knowledge system that includes ontologies and databases to facilitate computerized collection, organization, and retrieval of exposure, hazard, and susceptibility information. In addition, this system must be compatible and linkable to the larger environmental health universe of information to facilitate risk assessment for improved public health decisions (Davis et al., 2008; Judson et al., 2008; Richard et al., 2006 Richard et al., , 2008 . An exposure ontology consistent with those being used in toxicology and other health sciences is required to formally represent exposure concepts, the relationships between these concepts and most important the relationships between exposure, susceptibility, and toxicology domains. Lange et al. (2007) illustrate a framework for an interdisciplinary knowledge system to link agriculture, food science, nutrition, and health. Although this vision is presented in a slightly different context, the concept as outlined is directly relevant for 21st century human health risk assessment. Just as we are experiencing a transformation in toxicology, the food science community has seen a shift from discovery of essential nutrients for human survival to characterization of complex multifactorial interactions among food, diet, and health. The authors argue for standardized ontologies to define relationships, allow for automated reasoning, and facilitate meta-analyses. This same capability is clearly required to develop biologically relevant exposure metrics, design in vitro toxicity tests to measure environmentally relevant hazard, and to incorporate information on susceptibility and background exposures for interpretation of these data to assess real-world risks to individuals and populations.
EXPOSURE SCIENCE FOR THE 21ST CENTURY
The need for radical improvement in exposure science is not academic. Characterization of biologically relevant exposure is required to translate advances and findings in computational toxicology to information that can be directly used to support risk assessment for decision making and improved public health. New technologies must be applied to both toxicology and exposure science if the ultimate goal of evaluating risk to humans is to be achieved. Just as authors of the NRC (2007a) report recognize the need for broad-based support to achieve their vision for toxicity testing, realization of objectives for 230 HUBAL 21st century risk assessment will require significant investment in exposure science and development of capacity across both the public and the private sector. Ultimately, this additional investment will maximize contributions of emerging toxicity testing approaches toward improved understanding of relationships between environmental factors and human health outcomes.
Recognition that improvement in exposure science is required to characterize and manage risks associated with environmental stressors is broad based. A National Academies workshop conducted in June 2009, Exposure Science in the 21st Century, focused on the role of exposure science in health studies, risk assessment, and risk prevention (NRC, 2009) . At this workshop, the director of US EPA's National Exposure Research Laboratory announced plans for a new National Academies committee on exposure science in the 21st century (Reiter, 2009 ). Formation of this committee would be a critical step toward building the scientific basis for exposure characterization to protect environmental and public health. At the same time, the risk assessment community cannot wait to initiate important research in exposure science to meet rapid advances in toxicity testing and critical needs for translating emerging HTP hazard data if the NRC (2007a) vision is to be realized.
